Suggestions

Du même auteur

Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial

Archive ouverte | Taieb, Julien | CCSD

International audience. Purpose: Circulating tumor DNA (ctDNA) has been suggested as a major prognostic factor in resected stage-III colon cancer. We analyzed ctDNA of patients randomized in the phase III IDEA-Franc...

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial

Archive ouverte | André, Thierry | CCSD

IF 26.303 (2017). International audience. Purpose : Reduction of adjuvant treatment duration may decrease toxicities without loss of efficacy in stage III colon cancer. This could offer clear advantages to patients...

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials

Archive ouverte | Aparicio, Thomas, T. | CCSD

IF 7.191 (2017). International audience. BACKGROUND:Previous studies showed that high and low body mass index (BMI) was associated with worse prognosis in early-stage colorectal cancer (CRC), and low BMI was associa...

Chargement des enrichissements...